Skip to main content

Table 1 Characteristics of studies included in the meta-analysis

From: Association of CYP1A1 MspI polymorphism in the esophageal cancer risk: a meta-analysis in the Chinese population

Reference

Source of controls

Geographical locations

Histopathology type

Case number

Control number

Case

Control

HWE

      

TT

CT

CC

TT

CT

CC

χ 2

P

Wu 2002 [16]

HB

Taiwan

ESCC

146

344

60

65

21

136

146

62

4.16

0.041

Li 2002 [17]

HB

Shaxi

NS

73

75

20

30

23

37

25

13

4.96

0.026

Yin 2005 [18]

HB

Jiangsu

ESCC

106

106

42

54

10

41

49

16

0.05

0.829

Zhu 2005 [19]

HB

Shaxi

ESCC + EAC

163

166

43

75

45

75

67

24

1.96

0.162

Han 2005 [20]

HB

Shaxi

ESCC

89

98

25

39

25

47

38

13

1.37

0.241

Lu 2006 [21]

PB

Xinjiang

ESCC

64

116

23

28

13

44

56

16

0.07

0.786

Yin 2010 [22]

HB

Xinjiang

NS

96

174

16

45

35

17

88

69

2.13

0.144

Ji 2010 [23]

PB

Gansu

ESCC

189

216

49

95

45

70

98

48

1.49

0.222

Gao 2012 [24]

PB

Ningxia

ESCC

40

80

15

17

8

28

41

11

0.43

0.511

Huang 2012 [25]

PB

Guangxi

ESCC

98

100

38

41

19

40

43

17

0.85

0.358

Zhang 2013 [26]

PB

Shandong

ESCC

138

170

34

78

26

59

83

28

0.02

0.896

Yun 2014 [27]

PB

Henan

ESCC

157

157

73

72

12

95

50

12

2.11

0.146

Zhang 2011 [28]

PB

Henan

ESCC + EAC

160

160

97

63

128

32

-

  1. PB population-based, HB hospital-based, ESCC esophageal squamous cell carcinoma, EAC esophageal adenocarcinoma, NS not stated.